- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02288611
The Impact of Palm Date Intake on Colon Health Biomarkers (AJWA)
November 6, 2014 updated by: Jeremy Paul Edward Spencer, University of Reading
A Randomised, Controlled Intervention Trial to Assess the Impact of Palm Date Intake on Markers of Large Intestinal Health
This aim of this study is to investigate the prebiotic potential of date fruits in healthy human volunteers compared to a control diet.
Each arm was 21 days in duration, separated by a 14 days washout period.
Faecal samples, and blood samples will be collected from each volunteer and high resolution analytical techniques (HPLC, LC-MS and NMR) will be employed to characterise the whole system metabolic response to ingestion of date fruits compared to the control.
Changes in microbial parameters and metabolite profiles will be correlated with changes in biomarkers of chronic disease, including faecal water genotoxicity, cellular reactions, blood lipids and bowel movements.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This aim of this study is to investigate the prebiotic potential of date fruit consumption in healthy human volunteers compared to a diet which does not contain dates; control (maltodextrin-dextrose, 40.2g) or intervention treatment 7 date fruits (50g) to 22 healthy human volunteers.
Each arm was 21 days in duration, separated by a 14 days washout period.
Thus, we will also address fundamental questions about the relationship between fermentation of non digestible carbohydrates, the gut microbiota and the changes in faecal short chain fatty acids (SCFA profiles), ammonia and bile acids.
To this end faecal samples, and blood samples will be collected from each volunteer and high resolution analytical techniques (High Performance Liquid Chromatography; Liquid Chromatography-Mass Spectrometry and Nuclear Magnetic Resonance) will be employed to characterise the whole system metabolic response to ingestion of date fruits compared to the control.
Changes in microbial parameters and metabolite profiles will be correlated with changes in biomarkers of chronic disease, including faecal water genotoxicity, cellular reactions, blood lipids and bowel movements.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 55 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Signed consent form
- Body mass index - 18.5 - 30 inclusive
- Age 18 - 55 years
- Good general health as determined by medical questionnaires Requirements for diet and medication during study
- No intake of additional supplementary prebiotics (i.e. such as fructo-oligosaccharides) - please note that consumption of foods that are naturally prebiotic, e.g. cereal grains and leeks, may be consumed as normal
- No intake of probiotics (i.e. live yoghurts), drugs active on gastrointestinal motility, antibiotic treatment or any class of laxative
- All concomitant medication must be recorded in diaries and case record forms
- Usual diet, fluid intake and exercise levels should be maintained during trial period
- Please inform the investigator if you consume antibiotics during the trial. You will not be able to continue, as this may affect your faecal bacteria.
Exclusion Criteria:
- Requirements to take long-term medication active on the gastro-intestinal tract
- Use of antibiotics within the previous 6 months
- Anaemia
- Diabetes mellitus
- History of alcohol or drug abuse
- Current smoker
- Intake of any experimental drug within 4 weeks of the start of the study
- Excessive alcohol consumption (more than 21 units/wk male, 14 units/wk female)
- Females who are breast-feeding, may be pregnant, or if of child-bearing potential and are not using effective contraceptive precautions
- Major surgery, which might limit participation in, or completion of, the study.
- Participation in a study involving prebiotics or probiotics within the previous 3 months
- Physical or mental diseases that are likely to limit participation or completion of the study
- Severe allergy to foods or severe abnormal drug reactions
- Chronic gastroenterological complaints
- Intake of other supplementary prebiotics or probiotics, drugs active on gastrointestinal motility, or a laxative of any class during or within the four weeks prior to the start of the study
- Aged below 18 or over 55 years
- Have a BMI of less than 18.5 or more than 30
- Gluten allergy
- Calorie restriction or other special diet (e.g. Atkins diet, montignac diet) 6 weeks prior to the start of the study
- Vaccination against with the current season's influenza and AH1N1 flu
- Manifestation of allergy, asthma and dermatitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Maltodextrin/Dextrose mix
Twenty-two healthy human individuals were randomly assigned to consume a control (maltodextrin-dextrose, 40.2g) at one of the arms period. Each arm was 21 days in duration, separated by a 14 days washout period. P.S. placebo is called control in this study, where the bioactive comparator is a fruit. |
Twenty-two healthy human individuals were randomly assigned to consume 7 date fruits (approx.
50g).
Each arm was 21 days in duration, separated by a 14 days washout period.
Other Names:
|
|
Active Comparator: Date fruit - Ajwa variety
Twenty-two healthy human individuals were randomly assigned to consume date fruits (approx.
50g) at one of the arms period.
Each arm was 21 days in duration, separated by a 14 days washout period.
|
Twenty-two healthy human individuals were randomly assigned to consume Maltodextrin/dextrose , 40.2g.
Each arm was 21 days in duration, separated by a 14 days washout period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in large intestinal microbiota composition verses control intervention (0-3 months)
Time Frame: 3 months
|
Microbial profile assessed by FISH
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in Bowel function verses the control intervention (0-3 months
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: JEREMY PE SPENCER, PhD, UNIVERSITY OF READING - FOOD AND NUTRITIONAL SCIENCES DEPARTMENT
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
November 3, 2014
First Submitted That Met QC Criteria
November 6, 2014
First Posted (Estimate)
November 11, 2014
Study Record Updates
Last Update Posted (Estimate)
November 11, 2014
Last Update Submitted That Met QC Criteria
November 6, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AJWA STUDY
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.